SCHEMBL25252247

SCHEMBL25252247

CC1(C)OB(c2cn(C(=O)O)c3c(C#N)c(Cl)ccc23)OC1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25028792 0.85 USP30 (0.33) —
SCHEMBL29005554 0.79 ELANE (0.33) —
SCHEMBL25029242 0.73 PRMT5 (0.33) —
SCHEMBL29363521 0.73 PRMT5 (0.33) —
SCHEMBL19876637 0.73 PTGDR2 (0.31) —
SCHEMBL25029112 0.72 BACE1 (0.34) —
SCHEMBL17504507 0.71 JAK2 (0.31) —
SCHEMBL30673620 0.70 UCHL1 (0.33) —
SCHEMBL31104104 0.69 JAK2 (0.36) —
SCHEMBL22119838 0.69 LPL (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4182320-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS Nido Biosciences, Inc. (US) 2023-05-24 — — EP disclosed
WO-2022020342-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. (US) 2022-01-27 — — WO disclosed
Send feedback